A high-content assay to identify small-molecule modulators of a cancer stem cell population in luminal breast cancer

Journal of Biomolecular Screening

Volumn 17, Issue 9, 2012, Pages 1211-1220

  Yoo, Byong Hoon ^a   Axlund, Sunshine Daddario ^b   Kabos, Peter ^b   Reid, Brian G ^a   Schaack, Jerome ^a   Sartorius, Carol A ^b   Labarbera, Daniel V ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b University School of Medicine   (United States)

Author keywords

cancer and cancer drugs; cytokeratin; high content screening; nuclear hormone regulation; stem cells

Indexed keywords

CYTOKERATIN 5; ESTROGEN RECEPTOR; ETRETIN; GESTAGEN; GREEN FLUORESCENT PROTEIN; ISOTRETINOIN; LUCIFERASE; MICONAZOLE; PROGESTERONE RECEPTOR; RETINOID;

ARTICLE; BREAST CANCER; CANCER STEM CELL; CELL EXPANSION; CELL POPULATION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; MOLECULAR LIBRARY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACITRETIN; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DISCOVERY; DRUG RESISTANCE, NEOPLASM; FEMALE; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; ISOTRETINOIN; KERATIN-5; LUCIFERASES; MICONAZOLE; NEOPLASTIC STEM CELLS; PROGESTERONE; PROGESTINS; PROMOTER REGIONS, GENETIC; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETINOIDS; SMALL MOLECULE LIBRARIES; TRETINOIN;

EID: 84866427443     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057112452138     Document Type: Article

References (30)

1. Prat A., Perou C. M. Deconstructing the molecular portraits of breast cancer. Mol. Oncol. 2011 ; 5 (1). 5-23
2. Osborne C. K., Schiff R. Mechanisms of endocrine resistance in breast cancer. Annu. Rev. Med. 2011 ; 62: 233-247
3. Sotiriou C., Neo S. Y., McShane L. M., Korn E. L., Long P. M., Jazaeri A., Martiat P., Fox S. B., Harris A. L., Liu E. T. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc. Natl. Acad. Sci. U. S. A. 2003 ; 100 (18). 10393-10398
4. Guedj M., Marisa L., de Reynies A., Orsetti B., Schiappa R., Bibeau F., Macgrogan G., Lerebours F., Finetti P., Longy M., et al. A refined molecular taxonomy of breast cancer. Oncogene. 2012 ; 31 (9). 1196-1206
5. Charafe-Jauffret E., Ginestier C., Iovino F., Wicinski J., Cervera N., Finetti P., Hur M. H., Diebel M. E., Monville F., Dutcher J., et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 2009 ; 69 (4). 1302-1313
6. Honeth G., Bendahl P. O., Ringner M., Saal L. H., Gruvberger-Saal S. K., Lovgren K., Grabau D., Ferno M., Borg A., Hegardt C. The CD44+/CD24-phenotype is enriched in basal-like breast tumors. Breast Cancer Res. 2008 ; 10 (3). R53
7. Horwitz K. B., Dye W. W., Harrell J. C., Kabos P., Sartorius C. A. Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts. Proc. Natl. Acad. Sci. U. S. A. 2008 ; 105 (15). 5774-5779
8. Bocker W., Moll R., Poremba C., Holland R., Van Diest P. J., Dervan P., Burger H., Wai D., Ina Diallo R., Brandt B., et al. Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept. Lab. Invest. 2002 ; 82 (6). 737-746
9. Lim E., Vaillant F., Wu D., Forrest N. C., Pal B., Hart A. H., Asselin-Labat M. L., Gyorki D. E., Ward T., Partanen A., et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 2009 ; 15 (8). 907-913
10. Kabos P., Haughian J. M., Wang X., Dye W. W., Finlayson C., Elias A., Horwitz K. B., Sartorius C. A. Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers. Breast Cancer Res. Treat. 2011 ; 128: 45-55
11. Abd El-Rehim D. M., Pinder S. E., Paish C. E., Bell J., Blamey R. W., Robertson J. F., Nicholson R. I., Ellis I. O. Expression of luminal and basal cytokeratins in human breast carcinoma. J. Pathol. 2004 ; 203 (2). 661-671
12. Joshi P. A., Jackson H. W., Beristain A. G., Di Grappa M. A., Mote P. A., Clarke C. L., Stingl J., Waterhouse P. D., Khokha R. Progesterone induces adult mammary stem cell expansion. Nature. 2010 ; 465 (7299). 803-807
13. Beral V., Reeves G., Bull D., Green J. Breast cancer risk in relation to the interval between menopause and starting hormone therapy. J. Natl. Cancer Inst. 2011 ; 103 (4). 296-305
14. Axlund S. D., Sartorius C. A. Progesterone regulation of stem and progenitor cells in normal and malignant breast. Mol. Cell. Endocrinol 357. 2012 ; (1-2). 71-79
15. Chaffer C. L., Brueckmann I., Scheel C., Kaestli A. J., Wiggins P. A., Rodrigues L. O., Brooks M., Reinhardt F., Su Y., Polyak K., et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc. Natl. Acad. Sci. U. S. A. 2011 ; 108 (19). 7950-7955
16. Iliopoulos D., Hirsch H. A., Wang G., Struhl K. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc. Natl. Acad. Sci. U. S. A. 2011 ; 108 (4). 1397-402
17. Li Q., Chen C., Kapadia A., Zhou Q., Harper M. K., Schaack J., LaBarbera D. V. 3D Models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen. J. Biomol. Screen. 2011 ; 16 (2). 141-154
18. Byrne C., Fuchs E. Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice. Mol. Cell. Biol. 1993 ; 13 (6). 3176-3190
19. Zhang J. H. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J. Biomol. Screen. 1999 ; 4 (2). 67-73
20. Couzinet B., Le Strat N., Ulmann A., Baulieu E. E., Schaison G. Termination of early pregnancy by the progesterone antagonist RU 486(Mifepristone). N. Engl. J. Med. 1986 ; 315 (25). 1565-1570
21. Jordan C. T., Guzman M. L., Noble M. Cancer stem cells. N. Engl. J. Med. 2006 ; 355 (12). 1253-1261
22. Patel S. A., Ndabahaliye A., Lim P. K., Milton R., Rameshwar P. Challenges in the development of future treatments for breast cancer stem cells. Breast Cancer (London). 2010 ; 2: 1-11
23. Jho S. H., Radoja N., Im M. J., Tomic-Canic M. Negative response elements in keratin genes mediate transcriptional repression and the cross-talk among nuclear receptors. J. Biol. Chem. 2001 ; 276 (49). 45914-45920
24. Ramot Y., Paus R., Tiede S., Zlotogorski A. Endocrine controls of keratin expression. Bioessays. 2009 ; 31 (4). 389-399
25. Duret C., Daujat-Chavanieu M., Pascussi J. M., Pichard-Garcia L., Balaguer P., Fabre J. M., Vilarem M. J., Maurel P., Gerbal-Chaloin S. Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor. Mol. Pharmacol. 2006 ; 70 (1). 329-339
26. Clarke C. L., Graham J., Roman S. D., Sutherland R. L. Direct transcriptional regulation of the progesterone receptor by retinoic acid diminishes progestin responsiveness in the breast cancer cell line T-47D. J. Biol. Chem. 1991 ; 266 (28). 18969-18975
27. Ihunnah C. A., Jiang M., Xie W. Nuclear receptor PXR, transcriptional circuits and metabolic relevance. Biochim. Biophys. Acta. 2011 ; 1812 (8). 956-963
28. Svecova L., Vrzal R., Burysek L., Anzenbacherova E., Cerveny L., Grim J., Trejtnar F., Kunes J., Pour M., Staud F., et al. Azole antimycotics differentially affect rifampicin-induced pregnane X receptor-mediated CYP3A4 gene expression. Drug Metab. Dispos. 2008 ; 36 (2). 339-348
29. Papi A., Guarnieri T., Storci G., Santini D., Ceccarelli C., Taffurelli M., De Carolis S., Avenia N., Sanguinetti A., Sidoni A., et al. Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells. Cell Death Differ. 2012 ;:
30. Liu R., Wang X., Chen G. Y., Dalerba P., Gurney A., Hoey T., Sherlock G., Lewicki J., Shedden K., Clarke M. F. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N. Engl. J. Med. 2007 ; 356 (3). 217-226